Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies



Rating:

Share or cite this content

Citations should be made in the following way:
A. Benjafield (Sydney, Australia), D. Tellez (San Diego, United States of America), M. Barrett (San Francisco, United States of America), R. Gondalia (San Francisco, United States of America), C. Nunez (San Diego, United States of America), J. Wedzicha (London, United Kingdom), A. Malhotra (San Diego, United States of America). An estimate of the European prevalence of COPD in 2050. 2866

Member's Comments

No comment yet.

Related content which might interest you: GBD 2017 estimates on asthma, COPD and other: challenges to measure respiratory disease worldwide Source: International Congress 2019 – The Global Burden of Disease, Global Alliance for Chronic Diseases and Forum of International Respiratory Societies and other international initiatives Year: 2019 Forecasts of COPD mortality in Australia: 2006-2025 Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD Year: 2010 Population prevalence of COPD Source: Eur Respir J 2008; 31: 218 Year: 2008 Estimates of chronic obstructive pulmonary disease in terms of prevalence, mortality and costs for England and Scotland for 2011 and 2030 Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Underdiagnosis of COPD in the Latin American PLATINO study and worldwide Source: Annual Congress 2013 –Composite variables in COPD and update of prevalence worldwide Year: 2013 Trends in worldwide asthma prevalence Source: Eur Respir J, 56 (6) 2002094; 10.1183/13993003.02094-2020 Year: 2020 Using pharmacy sales data to estimate treated COPD prevalence in Portugal Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 International trends in COPD mortality, 1995–2017 Source: Eur Respir J, 54 (6) 1901791; 10.1183/13993003.01791-2019 Year: 2019 Variations in the prevalence of childhood asthma and wheeze in MeDALL cohorts in Europe Source: ERJ Open Res, 3 (3) 00150-2016; 10.1183/23120541.00150-2016 Year: 2017 Prevalence of COPD in a general population Source: Eur Respir J 2005; 26: Suppl. 49, 593s Year: 2005 Prevalence of respiratory symptoms in subjects with and without COPD in 5 Latin American cities: the PLATINO study Source: Annual Congress 2007 - Environmental and clinical aspects of COPD Year: 2007 The longitudinal determinants of decline in COPD and asthma-COPD overlap in an Australian population Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012 Population surveillance in North West Adelaide: the population attributable risk (PAR) of atopy for asthma varies with age Source: Eur Respir J 2005; 26: Suppl. 49, 265s Year: 2005 Burden of COPD in some African and Asian countries Source: Annual Congress 2007 - Environmental and clinical aspects of COPD Year: 2007 The population attributable fraction of occupational COPD among Danish women Source: ERJ Open Res, 3 (2) 00075-2016; 10.1183/23120541.00075-2016 Year: 2017 The prevalence, the incidence and the cost of COPD exacerbations Source: Annual Congress 2011 - Epidemiology of COPD exacerbations Year: 2011